[HTML][HTML] Pathway-directed therapy in multiple myeloma
Multiple Myeloma (MM) is a malignant plasma cell disorder with an unmet medical need, in
particular for relapsed and refractory patients. Molecules within deregulated signaling …
particular for relapsed and refractory patients. Molecules within deregulated signaling …
[HTML][HTML] Pathway-Directed Therapy in Multiple Myeloma
L John, MT Krauth, K Podar, MS Raab - Cancers, 2021 - ncbi.nlm.nih.gov
Multiple Myeloma (MM) is a malignant plasma cell disorder with an unmet medical need, in
particular for relapsed and refractory patients. Molecules within deregulated signaling …
particular for relapsed and refractory patients. Molecules within deregulated signaling …
Pathway-Directed Therapy in Multiple Myeloma
L John, MT Krauth, K Podar, MS Raab - Cancers, 2021 - pubmed.ncbi.nlm.nih.gov
Multiple Myeloma (MM) is a malignant plasma cell disorder with an unmet medical need, in
particular for relapsed and refractory patients. Molecules within deregulated signaling …
particular for relapsed and refractory patients. Molecules within deregulated signaling …
Pathway-Directed Therapy in Multiple Myeloma
L John, MT Krauth, K Podar, MS Raab - Cancers, 2021 - cir.nii.ac.jp
抄録< jats: p> Multiple Myeloma (MM) is a malignant plasma cell disorder with an unmet
medical need, in particular for relapsed and refractory patients. Molecules within …
medical need, in particular for relapsed and refractory patients. Molecules within …
Pathway-Directed Therapy in Multiple Myeloma.
L John, MT Krauth, K Podar, MS Raab… - …, 2021 - search.ebscohost.com
Abstract Simple Summary: Multiple Myeloma is a cancer of plasma cells in the bone marrow.
While effective treatments are available and many patients can now live years with the …
While effective treatments are available and many patients can now live years with the …
[PDF][PDF] Pathway-Directed Therapy in Multiple Myeloma. Cancers 2021, 13, 1668
L John, MT Krauth, K Podar, MS Raab - 2021 - pdfs.semanticscholar.org
Multiple Myeloma (MM) is a malignant plasma cell disorder with an unmet medical need, in
particular for relapsed and refractory patients. Molecules within deregulated signaling …
particular for relapsed and refractory patients. Molecules within deregulated signaling …
Pathway-Directed Therapy in Multiple Myeloma
J Lukas, MT Krauth, K Podar, MS Raab - Cancers, 2021 - search.proquest.com
Multiple Myeloma (MM) is a malignant plasma cell disorder with an unmet medical need, in
particular for relapsed and refractory patients. Molecules within deregulated signaling …
particular for relapsed and refractory patients. Molecules within deregulated signaling …
Pathway-Directed Therapy in Multiple Myeloma.
L John, MT Krauth, K Podar, MS Raab - Cancers, 2021 - europepmc.org
Multiple Myeloma (MM) is a malignant plasma cell disorder with an unmet medical need, in
particular for relapsed and refractory patients. Molecules within deregulated signaling …
particular for relapsed and refractory patients. Molecules within deregulated signaling …
[HTML][HTML] Pathway-Directed Therapy in Multiple Myeloma
L John, MT Krauth, K Podar, MS Raab - Cancers, 2021 - mdpi.com
Simple Summary Multiple Myeloma is a cancer of plasma cells in the bone marrow. While
effective treatments are available and many patients can now live years with the disease …
effective treatments are available and many patients can now live years with the disease …